(Q43950407)

28 November 2017

title

Angiotensin blockade for hypertension: a promise fulfilled (English)

1 reference

28 November 2017

Hans R Brunner

1

1 reference

28 November 2017

Haralambos Gavras

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

359

1 reference

28 November 2017

issue

9311

1 reference

28 November 2017

page(s)

990-992

1 reference

Renin and aldosterone and the pathogenesis of hypertensive vascular damage

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Essential hypertension: renin and aldosterone, heart attack and stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2908062-5

7 January 2021

10.1016/S0140-6736(02)08062-5

Identifiers

DOI

1 reference

28 November 2017

1 reference